Elmwood Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $598K | Buy |
2,376
+114
| +5% | +$24.5K | 0.15% | 114 |
|
|
2026
Q1 | $492K | Sell |
2,262
-403
| -15% | -$89.4K | 0.14% | 121 |
|
|
2025
Q4 | $609K | Buy |
2,665
+4
| +0.2% | +$911 | 0.19% | 107 |
|
|
2025
Q3 | $616K | Buy |
2,661
+745
| +39% | +$152K | 0.22% | 93 |
|
|
2025
Q2 | $356K | Sell |
1,916
-25
| -1% | -$4.65K | 0.14% | 104 |
|
|
2025
Q1 | $407K | Sell |
1,941
-165
| -8% | -$32.1K | 0.17% | 104 |
|
|
2024
Q4 | $374K | Sell |
2,106
-79
| -4% | -$14.5K | 0.15% | 106 |
|
|
2024
Q3 | $432K | Sell |
2,185
-100
| -4% | -$18.7K | 0.18% | 101 |
|
|
2024
Q2 | $392K | Hold |
2,285
| – | – | 0.17% | 98 |
|
|
2024
Q1 | $416K | Buy |
2,285
+320
| +16% | +$55.1K | 0.18% | 98 |
|
|
2023
Q4 | $305K | Sell |
1,965
-362
| -16% | -$52.8K | 0.21% | 92 |
|
|
2023
Q3 | $347K | Buy |
2,327
+25
| +1% | +$3.67K | 0.17% | 101 |
|
|
2023
Q2 | $310K | Sell |
2,302
-20
| -0.9% | -$2.93K | 0.14% | 104 |
|
|
2023
Q1 | $370K | Buy |
2,322
+137
| +6% | +$20.9K | 0.17% | 97 |
|
|
2022
Q4 | $353K | Hold |
2,185
| – | – | 0.18% | 98 |
|
|
2022
Q3 | $293K | Hold |
2,185
| – | – | 0.15% | 100 |
|
|
2022
Q2 | $335K | Hold |
2,185
| – | – | 0.19% | 93 |
|
|
2022
Q1 | $354K | Hold |
2,185
| – | – | 0.18% | 94 |
|
|
2021
Q4 | $296K | Buy |
+2,185
| New | +$258K | 0.14% | 104 |
|
|
2021
Q2 | $218K | Hold |
1,935
| – | – | 0.11% | 106 |
|
|
2021
Q1 | $209K | Buy |
+1,935
| New | +$207K | 0.13% | 101 |
|
|
2020
Q3 | $218K | Hold |
2,218
| – | – | 0.18% | 83 |
|
|
2020
Q2 | $218K | Sell |
2,218
-128
| -5% | -$11.3K | 0.18% | 83 |
|
|
2020
Q1 | $222K | Buy |
+2,346
| New | +$200K | 0.21% | 84 |
|
|
2019
Q4 | – | Sell |
-2,346
| Closed | -$178K | – | 88 |
|
|
2019
Q3 | $178K | Hold |
2,346
| – | – | 0.18% | 79 |
|
|
2019
Q2 | $171K | Hold |
2,346
| – | – | 0.15% | 88 |
|
|
2019
Q1 | $189K | Hold |
2,346
| – | – | 0.17% | 87 |
|
|
2018
Q4 | $216K | Hold |
2,346
| – | – | 0.21% | 84 |
|
|
2018
Q3 | $222K | Hold |
2,346
| – | – | 0.18% | 87 |
|
|
2018
Q2 | $217K | Hold |
2,346
| – | – | 0.2% | 88 |
|
|
2018
Q1 | $222K | Buy |
+2,346
| New | +$258K | 0.21% | 84 |
|
Other funds holding ABBV
Elmwood Wealth Management's ABBV Position: Q2 2026 in Review
Elmwood Wealth Management increased its AbbVie (ABBV) stake by 5% in Q2 2026, buying an estimated $24.5K and bringing the position to 2,376 shares worth $598K. The position accounts for 0.15% of the portfolio, ranked #114.
Elmwood Wealth Management first reported a position in ABBV in Q1 2018 and has held it in 31 quarters since. The position peaked at $616K in Q3 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Elmwood Wealth Management held 2,376 shares of AbbVie worth $598K as of Q2 2026.
- Elmwood Wealth Management bought 114 AbbVie shares in Q2 2026, an estimated $24.5K.
- AbbVie made up 0.15% of Elmwood Wealth Management's portfolio in Q2 2026, its #114 holding.
- Elmwood Wealth Management first reported a position in AbbVie in Q1 2018 and has held it in 31 quarters since.
- Elmwood Wealth Management's AbbVie position peaked at $616K in Q3 2025.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Elmwood Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.